Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Aug. 26, 1999

Academic researchers identify MAb as effective treatment for PCP addiction

Aug. 25, 1999

New treatments for alcoholism reported by Lipha

Aug. 23, 1999

Pfizer reveals new series of nicotinic acetylcholine receptor-modulating agents

Aug. 17, 1999

Therapeutic Antibodies submits PLA and ELA for DigiTAb

Aug. 12, 1999

BP-897, a partial dopamine D3 receptor agonist with potential in treating cocaine dependency

Aug. 2, 1999

Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal

July 12, 1999

LecTec granted patents on cotinine for smoking cessation and psychiatric disorders

July 7, 1999

Orphan Medical's Antizol injection receives approval in the U.K.

June 29, 1999

Cantab's vaccine for cocaine addiction shows encouraging phase I results

June 18, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...